Form 4 · Filed Jul 17, 2026, 05:50 PM UTC
ELV/Elevance Health, Inc.
BOUDREAUX GAIL — President and CEO
AI Thesis
A thesis has not been generated for this filing yet — usually available within 60 seconds of EDGAR publication. Refresh shortly.
Research signal, not investment advice. Form 4 AI surfaces SEC filings and applies an analytical layer — it does not predict prices or recommend trades. Past performance does not guarantee future results. See methodology and public track record for how scores are computed.
Transactions
2 rows| Date | Code | Direction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Jul 17, 2026 | P | buy | 680 | $366 | $249,159 | 169,931 |
| Jul 17, 2026 | P | buy | 2,045 | $368 | $753,071 | 171,976 |
Source: SEC EDGAR raw filing ↗ · Accession 0001287920-26-000006